However, the limitation of this study is that changes of MCT4 expression and activity in IBD remain to be addressed, and further work is required to demonstrate how MCT4 regulated CREB/NF‐κB activity, whether in MAPK‐dependent way, although lacking strong evidences to confirm it at present. Here, NFKB1 is linked to inflammatory bowel disease.